<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药时代 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-16T11:08:37+08:00</updated>
  <subtitle>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>进博之声：罗家立、陈力博士等行业领袖畅谈创新驱动医药行业共融发展</title>
    <updated>2020-11-15T22:23:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/nNgyb5QSaqcCg0Wvf1f6aQ</id>
    <link href="https://mp.weixin.qq.com/s/nNgyb5QSaqcCg0Wvf1f6aQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访陈凯先院士：中国制药要努力迈向“原始创新”</title>
    <updated>2020-11-15T22:23:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/oblhdBhaSNpVXiCa453bxg</id>
    <link href="https://mp.weixin.qq.com/s/oblhdBhaSNpVXiCa453bxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>招聘｜新药研发CMC总监/药化研究员</title>
    <updated>2020-11-15T22:23:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/59Oz6Ps_jiVklNvpxikY6A</id>
    <link href="https://mp.weixin.qq.com/s/59Oz6Ps_jiVklNvpxikY6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>本固枝荣，共赢之道--医保支付与本土创新药</title>
    <updated>2020-11-15T22:23:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/Q64M00vdkdWAnh768Vcgtw</id>
    <link href="https://mp.weixin.qq.com/s/Q64M00vdkdWAnh768Vcgtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PDF分享 | 谢雨礼博士：生物新技术到药物：跨越CMC鸿沟</title>
    <updated>2020-11-15T08:44:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/1chYwaA9PFhAWjMejkWLQA</id>
    <link href="https://mp.weixin.qq.com/s/1chYwaA9PFhAWjMejkWLQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>收购合作两开花，UCB加强基因疗法布局</title>
    <updated>2020-11-15T08:44:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/47PpY6VSvPmJ9YlqjZc8Jw</id>
    <link href="https://mp.weixin.qq.com/s/47PpY6VSvPmJ9YlqjZc8Jw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD47/SIRPα终于走向台前，吉利德、艾伯维成为主力阵营</title>
    <updated>2020-11-15T08:44:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/37BCryPrp4h47WbBiy3Dkw</id>
    <link href="https://mp.weixin.qq.com/s/37BCryPrp4h47WbBiy3Dkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 年许可交易纵览，国内生物技术公司进军国际</title>
    <updated>2020-11-15T08:44:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/HGPyke_fsuQ74XpWElAmOQ</id>
    <link href="https://mp.weixin.qq.com/s/HGPyke_fsuQ74XpWElAmOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专栏 | 控制策略：QbD中保证药品质量的直接武器</title>
    <updated>2020-11-14T08:54:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/Bx0_a_oHBUZGR8i7u6SqeQ</id>
    <link href="https://mp.weixin.qq.com/s/Bx0_a_oHBUZGR8i7u6SqeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风浪之后再起航——NASH领域获3500万美元融资</title>
    <updated>2020-11-14T08:54:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/JBvz2AMiVM_fxppXYcC9sA</id>
    <link href="https://mp.weixin.qq.com/s/JBvz2AMiVM_fxppXYcC9sA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美国礼来与万春医药子公司Seed Therapeutics合作开发泛素化靶向蛋白质降解新药</title>
    <updated>2020-11-14T08:54:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/fN53fOU4hN2ziJAox4GLeg</id>
    <link href="https://mp.weixin.qq.com/s/fN53fOU4hN2ziJAox4GLeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>牛俊奇教授：丙型肝炎筛查的经济学分析及策略</title>
    <updated>2020-11-14T08:54:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/yBrZBlWFXWJ2lN8cRt2tWA</id>
    <link href="https://mp.weixin.qq.com/s/yBrZBlWFXWJ2lN8cRt2tWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代独家转播 | 强生肺癌关注月特约——释放创新潜力，全面抗击肺癌</title>
    <updated>2020-11-13T17:02:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/k2d9eB7LdrvdWSEa5BJYEw</id>
    <link href="https://mp.weixin.qq.com/s/k2d9eB7LdrvdWSEa5BJYEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>沉寂数年的 Five Prime股价暴涨，bemarituzumab能否改变胃癌治疗现状？</title>
    <updated>2020-11-13T17:02:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/jjS1nI1K2luNYBQSaIqykw</id>
    <link href="https://mp.weixin.qq.com/s/jjS1nI1K2luNYBQSaIqykw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国科学家首获乙肝研究最高奖</title>
    <updated>2020-11-13T17:02:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/3ApwQpCr6Zs-jV1keSZDcw</id>
    <link href="https://mp.weixin.qq.com/s/3ApwQpCr6Zs-jV1keSZDcw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>甫康健康科技CEO沈孝坤：全力以赴研发新药解患者之需</title>
    <updated>2020-11-13T17:02:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/33wdamxJ5rm3J2JMngfVVg</id>
    <link href="https://mp.weixin.qq.com/s/33wdamxJ5rm3J2JMngfVVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤药物市场研发和BD  - 挡不住的诱惑，躲不开的风险</title>
    <updated>2020-11-13T17:02:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/vYe6UQsCpEDOrQI52gkh0A</id>
    <link href="https://mp.weixin.qq.com/s/vYe6UQsCpEDOrQI52gkh0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>精彩视频！一起欣赏2020中国新药CMC高峰论坛的难忘瞬间！</title>
    <updated>2020-11-12T07:05:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/uBtu7Ee2_UfplQnBkEQGOQ</id>
    <link href="https://mp.weixin.qq.com/s/uBtu7Ee2_UfplQnBkEQGOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>索元生物首个国际多中心III期临床试验顺利完成受试者入组</title>
    <updated>2020-11-12T07:05:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/MJHdWs-2sW6mqhFjpUzdOQ</id>
    <link href="https://mp.weixin.qq.com/s/MJHdWs-2sW6mqhFjpUzdOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>来了！第4代CAR-T细胞疗法上场！CAR-T细胞表达PD-1，实体瘤治疗效果大大增加</title>
    <updated>2020-11-12T07:05:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/gxjMOCIlxevNW2xxXkT72g</id>
    <link href="https://mp.weixin.qq.com/s/gxjMOCIlxevNW2xxXkT72g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>